Corrigendum cum addendum to the Notice of the Extra-Ordinary General Meeting to be held on 3rd June, 2025 at 03:00 PM through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has issued a corrigendum to its EGM notice originally dated 6th May 2025, following queries from BSE received on 16th May 2025. The company has revised the explanatory statements for Resolution No. 2 and Resolution No. 3, both of which relate to the preferential issue of equity shares (other than cash). The floor price for these allotments has been determined at Rs. 9.99 per share (Rs. 9.9859 rounded off), based on SEBI ICDR Regulation 166A pricing formula and a registered valuer's report, while the actual issue price stands at Rs. 10.00 per share. Additionally, a new Resolution No. 5 has been added to regularize the appointment of Ms. Pushpa Joshi (DIN: 06838093) as a Non-Executive and Independent Director for a 5-year term from 31st March 2025 to 30th March 2030. Ms. Joshi brings over six years of experience in financial management and office administration. The EGM will be held on 3rd June 2025 at 3:00 PM via video conferencing, and all other contents of the original EGM notice remain unchanged.
For shareholders, this means the preferential share allotment pricing has been clarified at Rs. 10 per share, which is at a slight premium to the floor price, and they will also vote on the regularization of an additional independent director at the upcoming EGM. The revisions are procedural clarifications in response to exchange queries, suggesting compliance-driven updates rather than material changes to the underlying proposals.